DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

STEMCELLS, INC.

NASDAQ: STEM


company name or ticker

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company

Investing In The Stem Cell Sector: An Overview

The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy

Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy

StemCells Management Discusses Q4 2012 Results - Earnings Call Transcript

Phase II Trials Will Be Pivotal For These Stem Cell Companies

4 Biotech Stocks Under $5 to Watch

Geron Earnings: An Early Look

Let's look forward to this company's next earnings report.

StemCells' Recent Share Price Drop

See More Articles...